Global Hemostats Market Size, Share Report, Analysis, Trends, Growth 2032
Hemostats Market Analysis By Product Type (Gelatin-based Hemostats, Thrombin-based, Collagen-based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, and Combination Hemostats), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.72 Billion | USD 4.33 Billion | 5.40% | 2023 |
What is the Hemostats market size?
The global Hemostats market size accrued earnings worth approximately USD 2.72 Billion in 2023 and is predicted to gain revenue of about USD 4.33 Billion by 2032, is set to record a CAGR of nearly 5.40% over the period from 2024 to 2032.
Global Hemostats Market: Overview
The hemostat is also known as arterial forceps or hemostatic clamp. It is a surgical tool that is used during major surgical procedures in order to control blood loss or halt bleeding during surgery. It is basically used in the early phases of surgery for an initial incision that closes blood vessels until ligation. Hemostats consist of a group of instruments that include pivot, tissue holders, needle holders, and various clamps. Reduce blood loss by hemostasis is the major challenge in any surgery. It can be achieved by various methods such as flowable and sealants, mechanical methods, active agents, thermal energy based devices, topical hemostatic agents, pharmaceutical agents, and thermal energy based devices. This procedure ensures strong adhesion of wound edges, rapid cessation of blood loss, tight sealing, prompt closure, reduced scarring, rapid healing, and reduced risk of infection.
Global Hemostats Market: Growth Factors
The hemostat clinical practice is growing very rapidly across the world thus anticipating boosting the global hemostats market growth. It offers lucrative growth opportunities for the market growth due to the presence of a pool of patients throughout the world. The affordable price of the tools expects to fuel the market growth. The surgical staple is the widely used tool to close the wounds. Topical hemostatic agents are broadly preferred as an alternative to standard suturing techniques in order to halt bleeding.
Hemostats Market: Report Scope
| Report Attributes | Report Details |
|---|---|
| Report Name | Hemostats Market |
| Market Size in 2023 | USD 2,724.7 Million |
| Market Forecast in 2032 | USD 4,328.6 Million |
| Growth Rate | CAGR of 5.40% |
| Number of Pages | 200 |
| Key Companies Covered | Anika Therapeutics, Inc., C.R. Bard, B. Braun Melsungen, Pfizer, 3-D Matrix, Ltd., Medtrade Products Ltd., Stryker, Baxter, Integra Lifesciences Corporation, Resorba Medical GmbH., and Vascular Solutions, Inc. Other influencing market players in the market are Gamma Therapeutics, Inc., Arch Therapeutics Inc., CSL Behring, Equimedical, B.V., Biom’Up SAS, Medline Industries, Inc., Hemostasis, LLC, CryoLife, Inc., Mallinckrodt Plc., Hemostasis, LLC, and Hemotec Medical GmbH. |
| Segments Covered | By Product Type, and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 - 2022 |
| Forecast Year | 2024 - 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Global Hemostats Market: Segmentation
The global hemostats market is bifurcated on the basis of product type and region. The product type segment includes gelatin-based hemostats, thrombin-based, collagen-based hemostats, oxidized regenerated cellulose based hemostats, and combination hemostats.
Global Hemostats Market: Regional Analysis
North America is the leading consumer of the hemostats which is followed by Europe and Asia-Pacific region. Various strategies are adopted by the market players such as joint ventures, new product launches, agreements, partnerships, and collaborations in order to enhance the market revenue in the North America which contributes to the market growth. Increasing healthcare infrastructure coupled with rise in the number of surgeries is projected to propel the market in Europe. Asia-Pacific is the fastest growing region owing to increasing number of surgeries and change in regulatory policies encourages the market in the region. Other major factors propelling the global hemostats market growth are swift adoption of innovative products, early adoption of highly developed technologies, and improved healthcare facilities in the region.
Global Hemostats Market: Competitive Players
The key market players that are dominating the hemostats market include
- Anika Therapeutics Inc.
- C.R. Bard
- B. Braun Melsungen
- Pfizer
- 3-D Matrix Ltd.
- Medtrade Products Ltd.
- Stryker
- Baxter
- Integra Lifesciences Corporation
- Resorba Medical GmbH.
- Vascular Solutions Inc.
- Gamma Therapeutics Inc.
- Arch Therapeutics Inc.
- CSL Behring
- Equimedical
- B.V.
- Biom’Up SAS
- Medline Industries Inc.
- Hemostasis LLC
- CryoLife Inc.
- Mallinckrodt Plc.
- Hemostasis LLC
- and Hemotec Medical GmbH.
By product type
- Gelatin-based hemostats
- Thrombin-based
- Collagen-based hemostats
- Oxidized regenerated cellulose based hemostats
- Combination hemostats
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table Of Content
Methodology
FrequentlyAsked Questions
Hemostats are medical agents or devices used to stop bleeding during surgical procedures. They help promote blood clotting and wound control.
The global hemostats market is expected to be driven by the rising surgical procedures, trauma care demand, and increasing use of advanced wound management products.
According to study, the global hemostats market size was worth around USD 2.72 Billion in 2023 and is predicted to grow to around USD 4.33 Billion By 2032.
The global hemostats market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 5.40% during the forecast period from 2024-2032.
The global hemostats industry is projected to be challenged by Major challenges include stringent regulatory approvals, compatibility with different surgical procedures, and cost pressures. Risk of adverse reactions and shelf-life stability are also concerns.
The Opportunities include growth in surgical procedures, trauma care demand, and advanced bioresorbable hemostatic agents. Minimally invasive surgeries and faster wound control drive innovation will offer significant growth opportunities in the hemostats market.
Bio-absorbable and rapid-acting formulations; minimally invasive surgical applications; advanced wound care innovations are the emerging trends and innovations impacting the hemostats market.
The global hemostats market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global hemostats market are; Anika Therapeutics, Inc., C.R. Bard, B. Braun Melsungen, Pfizer, 3-D Matrix, Ltd., Medtrade Products Ltd., Stryker, Baxter, Integra Lifesciences Corporation, Resorba Medical GmbH., and Vascular Solutions, Inc. Other influencing market players in the market are Gamma Therapeutics, Inc., Arch Therapeutics Inc., CSL Behring, Equimedical, B.V., Biom’Up SAS, Medline Industries, Inc., Hemostasis, LLC, CryoLife, Inc., Mallinckrodt Plc., Hemostasis, LLC, and Hemotec Medical GmbH. and others.
The report explores crucial aspects of the hemostats market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
